Recent experiments have demonstrated that NgR1 blockade can increase RGC axon regrowth as well as improve RGC survival in a variety of optic nerve pathologies, including glaucoma models, ischemic models, and following traumatic injury [27,28]. The gene discussed is RTN4R; the disease is glaucoma.